Akelos inc

A non opioid non addictive drug for neuropathic chronic pain, could dominate a 25 billion a year market because the drugs prescribed currently do not work , and mitigate the opioid crisis.

Facebook Twitter LinkedIn

A non opioid non addictive drug for neuropathic chronic pain, could dominate a 25 billion a year market because the drugs prescribed currently do not work , and mitigate the opioid crisis.
 
Please see attached file:
 

Ready to Ask For Funding for your company?

Post a Funding Request

Akelos inc is no longer seeking funding.